Subscribe

SEARCH RESULT

Wednesday, March 3, 2021
Elanco introduces vaccine for bovine pneumonia and BRD
Elanco Animal Health Incorporated has introduced NUPLURA PH+, providing fast, smooth and flexible protection against bovine respiratory disease (BRD), Bovine Veterinarian reported.
Tuesday, August 4, 2020
Elanco Brazil appoints new director general after completing Bayer animal health acquisition
United States-based Elanco Animal Health's Brazil unit appointed Sérgio Schuler as director general after the company concluded its purchase of Bayer's animal health division on August 3, Reuters reported.
Sunday, July 26, 2020
US approves Elanco's Bayer Animal Health acquisition
The US Federal Trade Commission (FTC) has given unanimous approval to Elanco Animal Health Incorporated for its acquisition of Bayer Animal Health, a division of Bayer AG, Southeast AgNet reported.
Friday, July 17, 2020
Neogen plans to acquire US rightsto Elanco's cattle insecticide
NEOGEN Corporation announced July 16 that, in line with the US Federal Trade Commission (FTC) July 15 press release, it plans to acquire the US rights to Elanco's StandGuard® Pour-on for horn fly and lice control in beef cattle, and re ...
Wednesday, July 15, 2020
Elanco decides against Bayer's Canadian rights in deal, set to divest brands
Elanco Animal Health will divest two of its brands and forgo obtaining Bayer AG's Canadian distribution rights to poultry insecticides as it completes its US$7.6 billion deal to buy Bayer's veterinary drugs unit, Reuters reported.
Tuesday, June 9, 2020
Elanco announces target date for closing Bayer deal
Elanco Animal Health has announced that it will complete its acquisition of Bayer Animal Health on August 3, the company stated in a Monday release, Kansas City Business Journal reported.
Monday, January 6, 2020
Elanco to present at the 38th Annual J.P. Morgan Healthcare Conference
January 6, 2020 Elanco to present at the 38th Annual J.P. Morgan Healthcare Conference Elanco Animal Health Incorporated (NYSE: ELAN) will participate in the 38th Annual J.P. Morgan Healthcare Conference on January 14, 2020, in San Francisc ...
Thursday, December 26, 2019
Elanco sells Canadian facility to aquaculture R&D firm
Elanco Animal Health Incorporated (NYSE: ELAN) has signed an agreement to sell its Victoria, Prince Edward Island (PEI) aqua research and development facility to The Center for Aquaculture Technologies Canada (CATC), a leading aquaculture R ...
Tuesday, December 3, 2019
Elanco Animal Health appoints new chief sustainability officer
December 3, 2019 Elanco Animal Health appoints new chief sustainability officer Elanco Animal Health Inc. has announced the appointment of Sara Place as the company's chief sustainability officer. The appointment underscores the company's c ...
Tuesday, October 8, 2019
Elanco advances margin expansion with business restructuring
October 8, 2019 Elanco advances margin expansion with business restructuring   Since its initial public offering last year, Elanco Animal Health Inc. has continued to evaluate its capabilities to meet its goal of becoming an agile company t ...
Monday, September 23, 2019
Elanco celebrates IPO's anniversary
September 23, 2019 Elanco celebrates IPO's anniversary Elanco Animal Health publicly marked on September 18 the first anniversary of its initial public offering (IPO) on September 20, 2018, and its transformation into an independent public ...
Tuesday, August 27, 2019
Elanco Animal Health provides capital backing to Stonehaven Incubate
Stonehaven Incubate, a business incubator that brings disruptive human health technologies to the animal sector, has received capital backing from the global animal health company Elanco Animal Health Incorporated.
Wednesday, August 21, 2019
Elanco confirms agreement to buy Bayer's animal health unit for US$7.6 billion
In an August 20 statement, Elanco has agreed to buy Bayer's animal health unit for US$7.6bn, as Bayer sells off assets in the face of soaring legal claims linked to its US$63-billion acquisition of Monsanto.
Thursday, July 18, 2019
Elanco collaborates with AgBiome for swine nutritional health innovation
Elanco Animal Health Incorporated (NYSE: ELAN) announced last month a new global R&D collaboration with AgBiome, Inc. to develop nutritional health products for swine.
Wednesday, January 30, 2019
Elanco, Performance Livestock Analytics establish data service agreement
January 30, 2019 Elanco, Performance Livestock Analytics establish data service agreement Performance Livestock Analytics, Inc. (PLA) and Elanco Animal Health Incorporated have recently announced an agreement to provide joint customers data ...
Video >
Most popular

Follow Us

FacebookTwitterLinkedIn
About Us
Company Profile
Our Team
Our Products & Services
Subscription
eNewsletter
Inquiry
Contact Us
Advertise With Us
Partner With Us
We use cookies to understand how you use our website and to improve your browsing experience.
This includes personalizing content and advertising. By continuing to use our website, you accept our use of cookies, updated Privacy Statement and Terms of Use.
Copyright ©2001 - 2024 eFeedLink. All rights reserved.